Showing results (971-980 of 1,482) with videos related to

Sort By:
Pageof 149
Human Psychopharmacology|February 8, 2012
Clinically relevant drug interactions in anxiety disordersMaria Rosaria Muscatello, Edoardo Spina, Borwin Bandelow, et al.
Human Psychopharmacology|January 18, 2012
Prescription profiles for pharmacological treatment of Japanese inpatients with schizophrenia: comparison between 2007 and 2009Takashi Yoshio, Toshiya Inada, Junji Uno, et al.
Human Psychopharmacology|January 10, 2012
Is antipsychotic treatment linked to low bone mineral density and osteoporosis? A review of the evidence and the clinical implicationsMatthieu P K Crews, Oliver D Howes
Human Psychopharmacology|December 14, 2011
Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trialsLeslie Citrome, Xiangyi Meng, Marla Hochfeld, et al.
Human Psychopharmacology|November 22, 2011
The effects of agomelatine on sexual function in depressed patients and healthy volunteersAngel Montejo, Susana Majadas, Sakina J Rizvi, et al.
Human Psychopharmacology|December 7, 2011
QT prolongation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite paliperidoneYutaro Suzuki, Naoki Fukui, Junzo Watanabe, et al.
Human Psychopharmacology|March 13, 2012
Phenazepam abuse in the UK: an emerging problem causing serious adverse health problems, including deathJohn Martin Corkery, Fabrizio Schifano, Abdol Hamid Ghodse
Human Psychopharmacology|October 21, 2014
Addition of an NK1 receptor antagonist to an SSRI did not enhance the antidepressant effects of SSRI monotherapy: results from a randomized clinical trial in patients with major depressive disorderWilliam A Ball, Duane B Snavely, Richard J Hargreaves, et al.
Human Psychopharmacology|March 18, 2020
The effectiveness of long-acting injectable antipsychotics versus oral antipsychotics in the maintenance treatment of outpatients with chronic schizophreniaSu-Chen Fang, Ding-Lieh Liao, Cheng-Yi Huang, et al.
Human Psychopharmacology|January 10, 2019
No evidence so far of a major role of AKT1 and GSK3B in the pathogenesis of antipsychotic-induced tardive dyskinesiaAnastasia Levchenko, Natalya Vyalova, Ivan V Pozhidaev, et al.
Pageof 149